BONE MİNERAL DENSITY İN MALE PATIENTS WITH IDIOPATHIC RECURRENT UROLITHIASIS

Volume: 42 Number: 3 September 1, 2003
  • İzzet Koçak
  • Yakup Yürekli
  • Mehmet Dündar
  • Burçin Özeren
EN TR

BONE MİNERAL DENSITY İN MALE PATIENTS WITH IDIOPATHIC RECURRENT UROLITHIASIS

Abstract

In this study, we aimed to determine bone mineral density (BMD) in male patients with a history of idiopathic recurrent urolithiasis under 60 years old. TWenty seven male patients having normal blood and urine biochemical parameters were included In the study. The mean age of patients was 49.7 (34-60). Dual-energy x-ray absorptiometry was performed on lumber spine (L2-L4) and proximal femur (femoral neck, Ward's triangle) using total BMD and Z score. Results were compared with those obtained in 14 healthy, age-matched male controls Without stone history. Lumber BMD, expressed as gr/cm2, were found to be lower in study group when compared to controls (0.91 ± 0.08 versus 1.13 ± 0.10 respectively, P< 0.01). The same significant decrease was seen in patient group when Z score of lumbar vertebra was taken into account (P< 0.01). We concluded that patients' vertebral bone loss and risk of osteopenia should be kept in mind In the management of idiopathic recurrent urolithiasis. We suggest that future prospective studies should be designed to probe the effect of specific interventions with calcium, both dietary and supplemental, on urinary parameters and BMD.

Keywords

Details

Primary Language

Turkish

Subjects

-

Journal Section

-

Authors

İzzet Koçak

Yakup Yürekli

Mehmet Dündar

Burçin Özeren

Publication Date

September 1, 2003

Submission Date

September 1, 2003

Acceptance Date

-

Published in Issue

Year 2003 Volume: 42 Number: 3

Vancouver
1.İzzet Koçak, Yakup Yürekli, Mehmet Dündar, Burçin Özeren. İDİOPATİK TEKRARLAYAN ÜRİNER SİSTEM TAŞLI ERKEKLERDE KEMİK MİNERAL YOĞUNLUĞU. EJM [Internet]. 2003 Sep. 1;42(3):179-82. Available from: https://izlik.org/JA65KW47DX

Ege Journal of Medicine enables the sharing of articles according to the Attribution-Non-Commercial-Share Alike 4.0 International (CC BY-NC-SA 4.0) license.